Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0EZ9C
|
||||
| Former ID |
DIB002518
|
||||
| Drug Name |
CTLA-4-XTEN
|
||||
| Synonyms |
Cytotoxic T-lymphocyte protein 4 modulator (XTEN, rheumatoid arthritis/transplant rejection), Amunix
|
||||
| Indication | Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] | Investigative | [543700] | ||
| Company |
Amunix Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Cytotoxic T-lymphocyte protein 4 | Target Info | Modulator | [543700] | |
| Pathway Interaction Database | Calcineurin-regulated NFAT-dependent transcription in lymphocytes | ||||
| Reactome | CTLA4 inhibitory signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.